Imperva Inc (IMPV.OQ)

IMPV.OQ on NASDAQ Stock Exchange Global Select Market

13 Dec 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company's products include its Imperva SecureSphere Paltform, Imperva... (more)


Beta: 1.83
Market Cap(Mil.): $1,535.19
Shares Outstanding(Mil.): 33.81
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 19.70 16.44
EPS (TTM): -- -- --
ROI: -- 16.04 10.62
ROE: -- 18.28 14.20

BRIEF-Imperv sees Q4 2017 non-GAAP Earnings per share $0.24 to $0.29

* Q3 earnings per share view $0.28 -- Thomson Reuters I/B/E/S

09 Nov 2017

BRIEF-Imperva sees Q3 revenue $83.5 mln to $84 mln

* Imperva announces positive preliminary third quarter 2017 financial results

20 Oct 2017

BRIEF-Imperva announces Chief Financial Officer transition

* Imperva Inc - ‍names Aaron Kuan interim Chief Financial Officer and commences CFO search​

10 Oct 2017

BRIEF-‍Elliott says its combined stake in Imperva Inc stands at about 9.5 pct of shares outstanding

* Elliott says it has reduced its position in Imperva Inc and its combined economic exposure, along with its affiliates, in the co stands at about 9.5% of shares outstanding Source text: (http://bit.ly/2xvsJGe) Further company coverage:

13 Sep 2017

BRIEF-Imperva names Christopher Hylen as president and CEO

* Imperva names Christopher Hylen as president and CEO as part of leadership transition

10 Aug 2017

BRIEF-YL Ventures expands advisory board with Akamai and Imperva executives for $75mln fund

* YL Ventures - Expansion of leadership team with additions of Andy Ellis, Chief Security Officer of Akamai Technologies, Amichai Shulman, Chief Technology Officer of Imperva, Inc Source text for Eikon: Further company coverage:

22 Jun 2017

Earnings vs. Estimates